Search

Your search keyword '"Moccia, Marcello"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Moccia, Marcello" Remove constraint Author: "Moccia, Marcello" Publisher elsevier bv Remove constraint Publisher: elsevier bv
73 results on '"Moccia, Marcello"'

Search Results

2. Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis

4. Exploring the relation between reserve and fatigue in multiple sclerosis

5. Epidemiology of multiple sclerosis in the Campania Region (Italy): Derivation and validation of an algorithm to calculate the 2015-2020 incidence

7. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

8. Multiple sclerosis progression: time for a new mechanism-driven framework

10. Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis

11. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020

12. Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019

13. A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing‐remitting multiple sclerosis

15. Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis

16. ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial

17. Ocrelizumab treatment in multiple sclerosis: Prospective real world observational multi-center study in Campania, Italy

20. Prevalence of SARS-CoV-2 antibodies in multiple sclerosis: The hidden part of the iceberg

21. Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis

22. Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group

27. The impact of diagnostic criteria and treatments on the 20-year costs for treating relapsing-remitting multiple sclerosis

29. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study

30. Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis

31. Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin

34. Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a

35. CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients

46. Impulsive-compulsive behaviors in Parkin-associated Parkinson's disease: a case-control study

48. Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study

49. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients

50. Quitting smoking: An early non-motor feature of Parkinson's disease?

Catalog

Books, media, physical & digital resources